RFG Advisory’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

RFG Advisory’s Portfolio SBIO Stock Details SBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-6,723	Closed	-$338K	–	447
2021 Q1	$338K	Hold	6,723	–	–	0.04%	317
2020 Q4	$371K	Hold	6,723	–	–	0.05%	290
2020 Q3	$277K	Sell	6,723 -500	-7%	-$20.6K	0.04%	331
2020 Q2	$302K	Buy	7,223 +575	+9%	+$22.7K	0.05%	289
2020 Q1	$211K	Buy	6,648 +200	+3%	+$7.65K	0.04%	311
2019 Q4	$273K	Buy	+6,448	New	+$239K	0.05%	306

Other funds holding SBIO

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

NAM

NTV Asset Management Charleston, West Virginia $910M AUM 27.02% 1-Year Est. Return

CCP

Cardan Capital Partners Denver, Colorado $893M AUM 22.82% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

RFG Advisory's SBIO Position: Q2 2021 in Review

RFG Advisory sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q2 2021, closing a stake of 6,723 shares — an estimated $338K sold.

RFG Advisory first reported a position in SBIO in Q4 2019 and held it in 6 quarters. The position peaked at $371K in Q4 2020. 66 funds tracked by Wall St. Rank hold SBIO as of Q2 2021.

RFG Advisory reported no remaining ALPS Medical Breakthroughs ETF position as of Q2 2021 after selling out during the quarter.
RFG Advisory sold 6,723 ALPS Medical Breakthroughs ETF shares in Q2 2021, an estimated $338K.
RFG Advisory first reported a position in ALPS Medical Breakthroughs ETF in Q4 2019 and held it in 6 quarters.
RFG Advisory's ALPS Medical Breakthroughs ETF position peaked at $371K in Q4 2020.
66 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q2 2021.

Based on RFG Advisory's 13F filing for Q2 2021, filed 29 Jul 2021.